Lars Henrik Dahl Hamnvik

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Combination Therapy

Top Venues

Journal of medical case reports

International journal of women's health

This page only lists publications with an associated author ORCID identifier.

Publications

Lars Henrik Dahl Hamnvik, Geir E Tjønnfjord, Signe Spetalen, Jakob Dalgaard
Long-lasting severe anemia following treatment with natalizumab for relapsing-remitting multiple sclerosis: a case report. Journal of medical case reports 18 (1) (2024)
Lars Henrik Dahl Hamnvik, Geir E Tjønnfjord, Signe Spetalen, Jakob Dalgaard
Long-lasting severe anemia following treatment with natalizumab for relapsing-remitting multiple sclerosis: a case report. Journal of medical case reports 18 (1) (2024)
Lars Henrik Dahl Hamnvik, Geir E Tjønnfjord, Signe Spetalen, Jakob Dalgaard
Long-lasting severe anemia following treatment with natalizumab for relapsing-remitting multiple sclerosis: a case report. Journal of medical case reports 18 (1) (2024)
Lars Henrik Dahl Hamnvik, Geir E Tjønnfjord, Signe Spetalen, Jakob Dalgaard
Long-lasting severe anemia following treatment with natalizumab for relapsing-remitting multiple sclerosis: a case report. Journal of medical case reports 18 (1) (2024)
Thomas Larsen Titze, Lars Henrik Dahl Hamnvik, Inga Marie Hauglum, Anne Elisabeth Tonay Carlsen, Lena Tjeldhorn, Nhan Trung Nguyen, Çiğdem Akalın Akkök
Management of Wrong Blood Transfusion to an RhD Negative Woman in Labor. International journal of women's health 15 (2023)
Thomas Larsen Titze, Lars Henrik Dahl Hamnvik, Inga Marie Hauglum, Anne Elisabeth Tonay Carlsen, Lena Tjeldhorn, Nhan Trung Nguyen, Çiğdem Akalın Akkök
Management of Wrong Blood Transfusion to an RhD Negative Woman in Labor. International journal of women's health 15 (2023)